Development of new postnatal diagnostic methods for chromosome disorders

Seminars in Fetal and Neonatal Medicine

Volumn 16, Issue 2, 2011, Pages 114-118

  Shaffer, Lisa G ^a   Bejjani, Bassem A ^a  

^a PerkinElmer   (United States)

Author keywords

Chromosome; Comparative genomic hybridization; Fluorescence in situ hybridization; Karyotype; Microarray

Indexed keywords

ARTICLE; CHILDHOOD DISEASE; CHROMOSOME ANALYSIS; CHROMOSOME BAND; CHROMOSOME DISORDER; CONGENITAL MALFORMATION; COPY NUMBER VARIATION; CYTOGENETICS; DISABILITY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPING; MICROARRAY ANALYSIS; MICROSCOPY; POSTNATAL CARE; POSTNATAL DIAGNOSIS;

CHROMOSOME DISORDERS; CYTOGENETICS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT, NEWBORN; KARYOTYPING; MICROARRAY ANALYSIS;

EID: 79951943283     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2010.11.001     Document Type: Article

References (56)

1. Pinkel D., Gray J.W., Trask B., van den Engh G., Fuscoe J., van Dekken H. Cytogenetic analysis by in situ hybridization with fluorescently labeled nucleic acid probes. Cold Spring Harbor Symp Quant Biol 1986, 51(Pt 1):151-157.
2. Atkins K.E., Gregg A., Spikes A.S., et al. Identification of Y chromatin directly in gonadal tissue by fluorescence in situ hybridization (FISH): significance for Ullrich-Turner syndrome screening in the cytogenetics laboratory. Am J Med Genet 2000, 91:377-382.
3. Driscoll D.A., Salvin J., Sellinger B., et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. J Med Genet 1993, 30:813-817.
4. Nickerson E., Greenberg F., Keating M.T., McCaskill C., Shaffer L.G. Deletions of the elastin gene at 7q11.23 occur in approximately 90% of patients with Williams syndrome. Am J Hum Genet 1995, 56:1156-1161.
5. Voskova-Goldman A., Peier A., Caskey C.T., Richards C.S., Shaffer L.G. DMD-specific FISH probes are diagnostically useful in the detection of female carriers of DMD gene deletions. Neurology 1997, 48:1633-1638.
6. Ligon A.H., Kashork C.D., Richards C.S., Shaffer L.G. Identification of female carriers for Duchenne and Becker muscular dystrophies using a FISH-based approach. Eur J Hum Genet 2000, 8:293-298.
7. Shaffer L.G., Kennedy G.M., Spikes A.S., Lupski J.R. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. Am J Med Genet 1997, 69:325-331.
8. Ligon A.H., Beaudet A.L., Shaffer L.G. Simultaneous, multilocus FISH analysis for detection of microdeletions in the diagnostic evaluation of developmental delay and mental retardation. Am J Hum Genet 1997, 61:51-59.
9. Klinger K., Landes G., Shook D., et al. Rapid detection of chromosome aneuploidies in uncultured amniocytes by using fluorescence in situ hybridization (FISH). Am J Hum Genet 1992, 51:55-65.
10. Anonymous A complete set of human telomeric probes and their clinical application. National Institutes of Health and Institute of Molecular Medicine collaboration. Nat Genet 1996, 14:86-89.
11. Knight S.J., Horsley S.W., Regan R., et al. Development and clinical application of an innovative fluorescence in situ hybridization technique which detects submicroscopic rearrangements involving telomeres. Eur J Hum Genet 1997, 5:1-8.
12. Ning Y., Rosenberg M., Biesecker L.G., Ledbetter D.H. Isolation of the human chromosome 22q telomere and its application to detection of cryptic chromosomal abnormalities. Hum Genet 1996, 97:765-769.
13. Ballif B.C., Kashork C.D., Shaffer L.G. FISHing for mechanisms of cytogenetically defined terminal deletions using chromosome-specific subtelomeric probes. Eur J Hum Genet 2000, 8:764-770.
14. Jalal S.M., Harwood A.R., Sekhon G.S., et al. Utility of subtelomeric fluorescent DNA probes for detection of chromosome anomalies in 425 patients. Genet Med 2003, 5:28-34.
15. Ravnan J.B., Tepperberg J.H., Papenhausen P., et al. Subtelomere FISH analysis of 11 688 cases: an evaluation of the frequency and pattern of subtelomere rearrangements in individuals with developmental disabilities. J Med Genet 2006, 43:478-489.
16. Ballif B.C., Kashork C.D., Shaffer L.G. The promise and pitfalls of telomere region-specific probes. Am J Hum Genet 2000, 67:1356-1359.
17. Pinkel D., Landegent J., Collins C., et al. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA 1988, 85:9138-9142.
18. Schröck E., du Manoir S., Veldman T., et al. Multicolor spectral karyotyping of human chromosomes. Science 1996, 273:494-497.
19. Veldman T., Vignon C., Schrock E., Rowley J.D., Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping. Nat Genet 1997, 15:406-410.
20. Williams C.A., Driscoll D.J., Dagli A.I. Clinical and genetic aspects of Angelman syndrome. Genet Med 2010, 12:385-395.
21. Neill N.J., Torchia B.S., Bejjani B.A., et al. Comparative analysis of copy number detection by whole-genome BAC and oligonucleotide array CGH. Mol Cytogenet 2010, 3:11.
22. Cross J., Peters G., Wu Z., et al. Resolution of trisomic mosaicism in prenatal diagnosis: estimated performance of a 50K SNP microarray. Prenat Diagn 2007, 7:1197-1204.
23. Bejjani B.A., Saleki R., Ballif B.C., et al. Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more?. Am J Med Genet A 2005, 134:259-267.
24. Miller D.T., Adam M.P., Aradhya S., et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010, 86:749-764.
25. Shevell M.I. The evaluation of the child with a global developmental delay. Semin Pediatr Neurol 1998, 5:21-26.
26. Shevell M.I., Bejjani B.A., Srour M., Rorem E.A., Hall N., Shaffer L.G. Array comparative genomic hybridization in global developmental delay. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:1101-1108.
27. Iafrate A.J., Feuk L., Rivera M.N., et al. Detection of large-scale variation in the human genome. Nat Genet 2004, 36:949-951.
28. Sebat J., Lakshmi B., Troge J., et al. Large-scale copy number polymorphism in the human genome. Science 2004, 305:525-528.
29. Sharp A.J. Emerging themes and new challenges in defining the role of structural variation in human disease. Hum Mutat 2009, 30:135-144.
30. Rosenfeld J.A., Coppinger J., Bejjani B.A., et al. Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. J Neurodev Disord 2010, 2:26-38.
31. Brunetti-Pierri N., Berg J.S., Scaglia F., et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008, 40:1466-1471.
32. Mefford H.C., Sharp A.J., Baker C., et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N Engl J Med 2008, 359:1685-1699.
33. Eichler E.E., Zimmerman A.W. A hot spot of genetic instability in autism. N Engl J Med 2008, 358:737-739.
34. Kumar R.A., KaraMohamed S., Sudi J., et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008, 17:628-638.
35. Weiss L.A., Shen Y., Korn J.M., et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008, 358:667-675.
36. Ullmann R., Turner G., Kirchhoff M., et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum Mutat 2007, 28:674-682.
37. Hannes F.D., Sharp A.J., Mefford H.C., et al. Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant. J Med Genet 2009, 46:223-232.
38. Friedman J.M., Baross A., Delaney A.D., et al. Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. Am J Hum Genet 2006, 79:500-513.
39. Tyreman M., Abbott K.M., Willatt L.R., et al. High resolution array analysis: diagnosing pregnancies with abnormal ultrasound findings. J Med Genet 2009, 46:531-541.
40. Adams S.A., Coppinger J., Saitta S.C., et al. Impact of genotype-first diagnosis: the detection of microdeletion and microduplication syndromes with cancer predisposition by aCGH. Genet Med 2009, 11:314-322.
41. Shaffer L.G., Theisen A., Bejjani B.A., et al. The discovery of microdeletion syndromes in the post-genomic era: review of the methodology and characterization of a new 1q41q42 microdeletion syndrome. Genet Med 2007, 9:607-616.
42. Willatt L., Cox J., Barber J., et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet 2005, 77:154-160.
43. Redon R., Baujat G., Sanlaville D., et al. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome. Eur J Hum Genet 2006, 14:759-767.
44. Sharp A.J., Mefford H.C., Li K., et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 2008, 40:322-328.
45. Coppinger J., McDonald-McGinn D., Zackai E., et al. Identification of familial and de novo microduplications of 22q11.21-q11.23 distal to the 22q11.21 microdeletion syndrome region. Hum Mol Genet 2009, 18:1377-1383.
46. Ballif B.C., Theisen A., Rosenfeld J.A., et al. Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities. Am J Hum Genet 2010, 86:454-461.
47. Sharp A.J., Selzer R.R., Veltman J.A., et al. Characterization of a recurrent 15q24 microdeletion syndrome. Hum Mol Genet 2007, 16:567-572.
48. Ballif B.C., Hornor S.A., Jenkins E., et al. Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. Nat Genet 2007, 39:1071-1073.
49. Rosenfeld J.A., Ballif B.C., Lucas A., et al. Small deletions of SATB2 cause some of the clinical features of the 2q33.1 microdeletion syndrome. PLoS One 2009, 4:e6568.
50. Wentzel C., Fernstrom M., Ohrner Y., Anneren G., Thuresson A.C. Clinical variability of the 22q11.2 duplication syndrome. Eur J Med Genet 2008, 51:501-510.
51. Berg J.S., Brunetti-Pierri N., Peters S.U., et al. Speech delay and autism spectrum behaviors are frequently associated with duplication of the 7q11.23 Williams-Beuren syndrome region. Genet Med 2007, 9:427-441.
52. Van der Aa N., Rooms L., Vandeweyer G., et al. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome. Eur J Med Genet 2009, 52:94-100.
53. Wang N.J., Liu D., Parokonny A.S., Schanen N.C. High-resolution molecular characterization of 15q11-q13 rearrangements by array comparative genomic hybridization (array CGH) with detection of gene dosage. Am J Hum Genet 2004, 75:267-281.
54. Shah P.S., Murthy P., Skidmore D., Shaffer L.G., Bejjani B.A., Chitayat D. Williams syndrome in a preterm infant with phenotype of Alagille syndrome. Am J Med Genet A 2008, 146A:2407-2411.
55. Koifman A., Feigenbaum A., Bi W., et al. A homozygous deletion of 8q24.3 including the NIBP gene associated with severe developmental delay, dysgenesis of the corpus callosum, and dysmorphic facial features. Am J Med Genet A 2010, 152A:1268-1272.
56. Rosenfeld J.A., Leppig K., Ballif B.C., et al. Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations. Genet Med 2009, 11:797-805.